GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

AER002   Click here for help

GtoPdb Ligand ID: 13723

Synonyms: AER-002 | P2G3
Compound class: Antibody
Comment: AER002 is a long-acting fully human anti-SARS-CoV-2 spike protein monoclonal antibody that blocks spike-ACE2 interactions, viral attachment and infection of host cells. It was isolated from post-COVID-19 patient plasma [1].
No information available.
Summary of Clinical Use Click here for help
AER002 is a clinical candadate for the treament of long COVID [2].
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT05877508 Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19) Phase 2 Interventional University of California, San Francisco The outSMART-LC study is designed to evaluate efficacy as treatment for established long COVID.